logo
[breadcrumb_custom]

Tag: (SCLX)

VIPS stock
Stock

Uncovering the Potential of Scilex Holding Company (SCLX) Stock

In terms of market performance, Scilex Holding Company had a fairly uneven. The highest value for the stock in the past year was $14.86 on 04/17/23, and the lowest value was recorded at $0.90 on 11/22/23. 52-week price history of SCLX Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Scilex Holding Company’s current trading price is -92.19% away from its 52-week high, while its distance from the 52-week low is 28.87%. The stock’s price range during the 52-week period has remained between $0.90 and

PNC Stock
News

SCLX’s Stock Woes: Down -6.08% in 6 Months, Down -6.08% in Just 5 Days

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -31.86%.However, over the last six months, we can see a stronger performance of -6.08%. Over the last 30 days, the price of SCLX has leaped by 0.00%. And in the last five days, it has fallen by -11.46%. Scilex Holding Company had a pretty Dodgy run when it comes to the market performance. Over

VIPS stock
Industry

Scilex Holding Company (SCLX) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Scilex Holding Company’s current trading price is -91.78% away from its 52-week high, while its distance from the 52-week low is 54.43%. The stock’s price range for this period has been between $0.90 and $16.90 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.15 million for the day, a number notably higher than the average daily volume of 0.95 million over the last three months. In terms of market performance, Scilex Holding